David Andrew Robins - 18 Jun 2024 Form 4 Insider Report for Autonomix Medical, Inc. (AMIX)

Role: Director
Signature: /s/ Trent Smith, Attorney-in-Fact for David Robins
Issuer symbol: AMIX
Transactions as of: 18 Jun 2024
Net transactions value: +$104
Form type: 4
Filing time: 26 Jul 2024, 16:06:58 UTC
Previous filing: 26 Jan 2024
SEC: View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	AMIX	Warrant (Right to buy)	Purchase	$104	+103,990	+1664%	$0.001000^*	110,240	18 Jun 2024	Common Stock	103,990	$0.001000	See footnote	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Includes a portion of 1,600,000 warrants to purchase shares of the Company's common stock that was held by Impulse Medical, Inc., in which Mr. Robins owns 19.5% through Portsmouth Therapeutics, Inc., an entity in which Mr. Robins also owns a 33.33% interest. The shares underlying the warrants are subject to a lockup agreement for a period of six months after January 29, 2024 with respect to 12.5% of the shares issued and twelve months after January 29, 2024 for the remainder of the shares.

Content

Includes a portion of 1,600,000 warrants to purchase shares of the Company's common stock that was held by Impulse Medical, Inc., in which Mr. Robins owns 19.5% through Portsmouth Therapeutics, Inc., an entity in which Mr. Robins also owns a 33.33% interest. The shares underlying the warrants are subject to a lockup agreement for a period of six months after January 29, 2024 with respect to 12.5% of the shares issued and twelve months after January 29, 2024 for the remainder of the shares.